Navigation Links
Ocera Therapeutics Receives Orphan Drug Status for AST-120 for Pouchitis
Date:1/7/2008

Company to Present at 26th Annual JP Morgan Healthcare Conference

SAN DIEGO, Jan. 7 /PRNewswire/ -- Ocera Therapeutics, Inc., a privately-held biopharmaceutical company focused on the development and commercialization of proprietary compounds to treat gastrointestinal and liver diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AST-120 for the treatment of Pouchitis.

Ocera will provide an overview of the Company and an update on AST-120 at the 26th Annual JP Morgan Healthcare conference being held today, at 2:30 pm (PT) at the Westin St. Francis Hotel in San Francisco in the Elizabethan Room.

"We are pleased by the FDA's decision to grant orphan drug status for AST-120 in Pouchitis," stated Dr. Laurent Fischer, president and CEO of Ocera Therapeutics. "This designation, along with the recent positive results from the exploratory Phase 2 trial for AST-120, allows us to expand the development of AST-120 for the treatment of Pouchitis, a frequent and severe complication in patients with a J-Pouch for which there are currently no drugs approved."

Patients who suffer from ulcerative colitis often require a resection of the colon and creation of a J-Pouch to reduce the risk of cancer. A J-Pouch collects stool, but the pouch can become inflamed, resulting in a condition known as Pouchitis, which is associated with diarrhea, abdominal cramps, fever and dehydration. AST-120, an oral agent known to adsorb bile acids and bacterial toxins, as well as to mediate inflammation in the gastrointestinal tract, is currently being evaluated in a Phase 2 trial in patients with active Pouchitis.

Less than 100,000 patients in the United States suffer from Pouchitis which qualifies AST-120 for Orphan Drug status in this condition. Orphan Drug status was created by the FDA to encourage companies to develop medicines for the treatment of rare diseases by providing the developer with mark
'/>"/>

SOURCE Ocera Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. National Patient Safety Foundation Partners with Vocera Communications
2. Prime Therapeutics Receives TIPPS Certification
3. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
4. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
5. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
6. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
7. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
8. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
9. Prime Therapeutics Announces URAC Accreditation
10. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
11. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Nike Swim Camps offer outstanding coaching by ... to stimulate a love of swimming in a positive ... the opportunity to train with some of the most ... President of US Sports Camps. “Our program directors provide ... confidence and improve their technique.” , Nike Swim Camp ...
(Date:3/4/2015)... California (PRWEB) March 04, 2015 ... therapeutics market is driven by the increasing incidence of ... encouraging pipeline of late stage drugs. The unmet medical ... fore the untapped potential in the market. Presently, there ... drugs that overcome the limitations of current generation drugs. ...
(Date:3/4/2015)... Ohio (PRWEB) March 04, 2015 Nitrosigine®, ... an ingredient in premium sports nutrition products, is hosting ... Trainer booth in the Terrace Ballroom at The Arnold ... from March 5, 2015 to March 8, 2015. ... silicate with FDA New Dietary Ingredient notification status; now ...
(Date:3/4/2015)... 2015 Follow us on LinkedIn ... the appearance of the skin and body, are witnessing ... therapeutic agents to achieve the desired product properties and ... obsessed with physical beauty, youth, and achievement. Demand for ... sales of cosmetics. Growth in the market is driven ...
(Date:3/4/2015)... The report “Vasculitis – Pipeline Review, ... for Vasculitis. Vasculitis is a disease that features tenderness ... diseases is not known. Vasculitis can affect any body ... Symptoms can include fever, weight loss, tiredness, aches, pains, ... a limb. Vasculitis is treatable, but it is not ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 4
... University of Utah researchers in the development and testing of ... would transmit the nerve impulses from nerves in the residual ... then to the bionic arm. This will facilitate the person ... ,Sensors placed in the artificial arm will be designed ...
... ocean currents in climate change and the story behind Antarctica’s ... to be holding the clue. ,An element pretty ... teeth has offered a clue to the University of Florida ... Atlantic and Pacific might have opened up. This has happened ...
... Administration is being prompted by the Drug Manufacturer, Wyeth ... hormone drugs to treat menopause.// The drugs are made ... approved. ,Following Wyeth's recommendation to the FDA, the ... on these custom-made treatments, and have requested the agency ...
... Functional and structural difference in the brain can explain ... in unique ways to the effects// of certain pain-relief ... Georgia State University and the Atlanta-based Center for Behavioral ... conducted on rat brains, the results highlight that similar ...
... a report by the Food and Agriculture Organisation (FAO) of ... animal species said that domestic and wild birds spread the ... accumulated since the start of the avian influenza crisis (the ... in the transmission of the virus in the natural setting. ...
... and as a clean up drive legalisation of drugs is ... free drugs to addicts// to help clean up the Downtown ... Sam Sullivan a donation by an anonymous donor of $500,000 ... ,The reason and goal behind this whole exercise would be ...
Cached Medicine News:Health News:Gender Difference In Pain Experience Explained By Brain Diversity 2
(Date:3/4/2015)... 4, 2015   Symbiomix Therapeutics , a ... for serious women,s health infections, today announced results ... its lead product candidate, SYM-1219, was safe and ... that contraceptive efficacy for birth control pills would ... These results will be presented on March 6 ...
(Date:3/3/2015)... 2015  The packaging industry plays a major ... provides containment and drug safety but also ensures ... patent loss delivers more generics into the market, ... turn encouraging low-cost innovation in emerging markets. The ... the pharmaceutical packaging industry towards low-cost, sustainable and ...
(Date:3/3/2015)... -- Vermillion, Inc. (NASDAQ: VRML ), a bio-analytical solutions ... at the 27 th Annual ROTH Conference, which is ... California from March 8 to March 11. ... , will be presenting on Monday, March 9 at 12:00 ... , the company,s Vice President of Finance and Chief Accounting ...
Breaking Medicine Technology:Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 2Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 3Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 4Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 5Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 2Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 3Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 4Vermillion To Present at 27th Annual ROTH Conference on March 9 2
... 8, 2010 George Products Company, Inc. has announced ... of its OASIS Inspection Systems. Florida ... southeast Florida. OASIS Inspection Systems is a line of ... to quality control departments across the United States. Tim ...
... 1st to the 3rd of March 2011, vaccine leaders ... World Summit in New Delhi. The event will be ... Vaccine Manufacturers Network). Participants will be discussing ... pandemic surveillance programs, low cost and fast vaccine manufacturing ...
Cached Medicine Technology:Florida Metrology To Distribute OASIS Inspection Systems 2World Vaccine Leaders to Meet in New Delhi India to Tackle Global Public Health Challenges 2
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
... Centuries of German ... finest surgical instrumentation in ... makes them available to ... the coveted Meisterbrief certificate, ...
Medicine Products: